found that CSW associates with the pY630 site (Cleghon
In addition, we demonstrate that CSW, the positive DN D-RasGAP). We then used the Gal4-UAS system effector of the Torso pY630 site, is phosphorylated by (Brand and Perrimon, 1993) to express either the DN Torso on Y666 and that pY666 serves as a binding site D-RasGAP construct or one encoding the full-length for DRK. Further, we find that Torso is a substrate of D-RasGAP in early embryos. The effect of the DN and CSW both in vitro and in vivo, that CSW specifically full-length D-RasGAP transgenes on the terminal pathdephosphorylates Torso at the pY918 negative signaling way was subsequently monitored by measuring tll exsite, and that this dephosphorylation event requires the pression in the posterior region of embryos at late syncybinding of CSW to pY630 of Torso. Thus, this study tial blastoderm stages. In WT embryos, tll is expressed identifies Torso to be a biologically relevant target of from 0%-15% egg length (EL) (average of 14.5% with CSW and indicates that by dephosphorylating the pY918 30 embryos; Figure 1A) . Expression of the UAS fullsite, CSW prevents the negative regulator RasGAP from length D-RasGAP transgene had no significant effect associating with Torso. In the context of the Drosophila on tll expression (average 14.7% with 30 embryos, data embryo, the competition between positive and negative not shown). However, expression of UAS-DN D-RasGAP signaling sites on Torso modulates the strength of the expanded the domain of tll expression to 0%-18% EL Torso signal, thereby defining the precise spatial ex-(average 18.3% with 30 embryos; Figure 1B (Figure 1 ; Cleghon et al., 1996). Therefore, we investigated whether D-RasGAP is the signaling molecule that transduces the negative effects of the Torso pY918 site. Because the mammalian RasGAP/RTK interaction is mediated by the binding of the RasGAP SH2 domains to specific pY residues on the RTK, we examined whether the isolated SH2 domains of D-RasGAP would associate with Torso in a pY-dependent manner. For this analysis, the SHS domains of D-RasGAP were expressed in bacteria as a glutathione S-transferase (GST) fusion protein. The GST-SHS fusion protein was then immobilized on glutathione Sepharose beads and incubated with Sf9 insect cell lysates containing constitutively active Torso (4021), kinase-inactive Torso (TKM), or pY mutant 4021-Torso proteins (Y630F, Y918F, or YY630/918FF). Following extensive washing, the GST-SHS complexes were examined for the presence of Torso by immunoblot analysis. As shown in Figure 2A , 4021 and Y630F Torso proteins associated with the D-RasGAP SHS domains, whereas unphosphorylated TKM or mutant proteins containing the Y918F substitution did not. These results indicate that D-RasGAP associates with Torso in a pY-specific manner requiring the Y918 site.
To confirm that the association with Torso was mediated by the SH2 domains of D-RasGAP, we mutated the Figure 2B , the mutant SHS protein was unable that is phosphorylated by Torso. For this study, CSW was coexpressed with Torso in Sf9 cells and analyzed was coexpressed with Torso in Sf9 cells and phosphoryas described above. As shown in Figure 3C , the peak lated by Torso in immune complex kinase assays.
of radioactivity eluting in fraction 14 was absent from 32 P-labeled CSW was then resolved by SDS-PAGE, ex-CSW
Y666F
, confirming that Y666 is the site of Torsotracted from the gel matrix, and digested with trypsin. dependent tyrosine phosphorylation. The resulting tryptic phosphopeptides were separated
The sequence context of the CSW Y666 site, pY-Tand eluted from a reversed-phase HPLC C-18 column. N-I, represents a consensus binding site for DRK (i.e., When the radioactivity released from the column was pY-X-N-X; Songyang et al., 1993). By genetic analysis, quantitated, a major peak in fraction 14 was detected DRK has been shown to be a positive effector of the ( Figure 3A ). Phosphoamino acid analysis and N-terminal terminal pathway (Hou et al., 1995); however, Torso does sequencing of the peptide isolated in fraction 14 renot contain a consensus DRK-binding site, nor has it vealed that it contained phosphotyrosine and was phosbeen found to directly associate with DRK (Cleghon et phorylated on the second residue after the trypsin cleaval., 1996). Therefore, to determine whether DRK indiage site ( Figure 3B ). By examining the amino acid rectly couples to the Torso receptor by interacting with sequence of CSW, we found that the only tyrosine located two residues downstream from a trypsin cleavage CSW at pY666, we performed binding experiments using findings establish the first physical link between the activated Torso receptor and Ras activation via the binding of CSW to Torso, DRK to CSW, and SOS to DRK.
pY918 of Torso Is a Specific Substrate of CSW Activity In Vitro
If the sole function of CSW is to serve as an adaptor protein linking DRK to Torso, then a catalytically inactive CSW molecule should be sufficient to fulfill this role. Indeed, the inactive CSW C583S mutant does bind Torso at pY630, is subsequently tyrosine phosphorylated on Y666 (data not shown), and is capable of binding DRK ( Figure 3D ). However, the enzymatic activity of CSW is required for CSW to transduce the Torso signal. Thus, the identification of CSW substrates is critical. Since the cellular colocalization of enzymes and their targets is an emerging theme in signal transduction and since CSW directly interacts with Torso, we examined whether the Torso receptor itself might be a substrate of CSW. For these experiments, we developed an in vitro phosphatase assay using soluble CSW and autophosphorylated 32 P-labeled Torso. CSW WT and phosphatase-inactive CSW C583S proteins were expressed in Sf9 cells and purified from crude lysates using ion exchange chromatography ( Figure 4A ).
P-labeled Torso was then incubated with various amounts of purified CSW WT and CSW

C583S
, and the radioactivity released from Torso was monitored. We found that CSW C583S displayed no detectable activity, whereas CSW WT was active as a phosphatase and was able to dephosphorylate Torso in vitro (Figure 4B) . Using a phosphotryptic/HPLC assay (Cleghon et al., 1996), we next investigated whether CSW displays Figure 5A ). To determine whether the observed reduction in tyrosine phosphorylation was due to the specific ther the non-tyrosine-phosphorylated CSW WT nor the CSW Y666F mutant that had been coexpressed with Torso dephosphorylation of the pY918 site, we used the isolated SHS domains of D-RasGAP as an affinity reagent were precipitated by the DRK fusion protein, demonstrating that DRK associates with CSW in a pY-depento measure the level of Torso pY918, since this fusion protein specifically interacts with the pY918 site (Figure dent manner that requires the pY666 site. Further, these was used as an affinity reagent to detect pY918, we then we would expect that Drosophila embryos lacking CSW activity would contain higher levels of pY918-containing Torso than would WT embryos. To address this question, embryos from WT or csw LE120 females were 2). The GST-SHS D-RasGAP fusion protein was incubated with the Sf9 cell lysates, and the associated collected at 0-3 hr after egg laying (a time where Torso is known to function) and examined for the level of Torso pY918-containing Torso was visualized by immunoblot analysis. As shown in Figure 5A , the level of pY918-pY918 using the isolated SHS domains of D-RasGAP. As shown in Figure 5C , the levels of pY918-containing containing Torso was readily detectable when Torso was expressed alone or coexpressed with CSW C583S ;
Torso were clearly elevated in embryos lacking CSW activity, indicating that Torso pY918 is a biologically however, the level was dramatically reduced when Torso was coexpressed with CSW WT (Figure 5A) 
pY-X-N-X). Since Torso itself D-RasGAP Is the Negative Effector of Torso pY918
does not contain a Y-X-N-X motif, the binding of DRK By combining biochemical and genetic approaches, we to CSW establishes the first physical link from Torso to have found that the Drosophila homolog of RasGAP the DRK-SOS-Ras activation cascade. SHP-2 has also specifically associates with pY918 of Torso and is a been found to serve as a DRK/Grb-2-binding protein in negative effector of the terminal pathway. As has been some RTK signaling pathways ( ‫%51ف(‬ EL), a reduction in the concentration of ligand produces a region where activated receptors are further apart. Under these conditions, dephosphorylation of that DOS functions in the terminal pathway, but whether pY918 by CSW would be expected to be less efficient, CSW also dephosphorylates DOS during Torso signaling allowing RasGAP to bind Torso and downregulate the awaits further analysis. Our study, however, identifies Torso/Ras signal. The ability to modulate the strength Torso to be a biologically relevant target of CSW in the of Torso signaling would provide several advantages. terminal pathway and indicates that by dephosphorylatFirst, it could accentuate and sharpen the differences ing the pY918 site, CSW prevents the negative regulator in the signaling gradient initiated by ligand concentraRasGAP from associating with Torso. These results are tion. In addition, the existence of positive and negative consistent with previous epistasis experiments indicatsignaling sites on Torso would be more amenable to ing that CSW functions upstream or parallel to Ras in regulatory controls than would the simple diffusion of the terminal pathway (Perkins et al., 1992; Lu et al., the Torso ligand. Thus, we propose that the function of 1993). In addition, the observation that the most severe the internal competition between the positive pY630 and CSW mutants cause less severe phenotypes than those negative Y918 signaling sites is to sharpen the gradient produced by the loss of the RTK itself further supports of MAPK activity induced by Torso, thereby defining the idea that CSW is involved in modulating the magniprecise boundaries for tll and hkb expression and subsetude of RTK signaling (Perkins et al., 1996) . Interestingly, the PDGF receptor has been identified as a substrate of quent terminal structure development. 
